Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease

被引:14
|
作者
Perumalsamy, Sangeetha [1 ]
Huri, Hasniza Zaman [1 ]
Abdullah, Bashar Mudhaffar [2 ]
Mazlan, Othman [1 ]
Ahmad, Wan Azman Wan [3 ]
Vethakkan, Shireene Ratna D. B. [4 ]
机构
[1] Univ Malaya, Fac Pharm, Dept Clin Pharm & Pharm Practice, Kuala Lumpur 50603, Malaysia
[2] Al Rafidain Univ Coll, Dept Med Labs Tech, Baghdad, Iraq
[3] Univ Malaya, Fac Med, Dept Med, Cardiol Unit, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Fac Med, Dept Med, Endocrinol Unit, Kuala Lumpur 50603, Malaysia
关键词
insulin resistance; type 2 diabetes mellitus; atherosclerosis; endothelial dysfunction; coronary artery disease; genetic markers; single nucleotide polymorphisms; GENOME-WIDE ASSOCIATION; CD36; GENE; METABOLIC SYNDROME; SERUM-LEVELS; POLYMORPHISM; INTERLEUKIN-18; RISK; VARIANTS; OBESITY; LOCUS;
D O I
10.3390/metabo13030427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion on a background of insulin resistance (IR). IR and T2DM are associated with atherosclerotic coronary artery disease (CAD). The mechanisms of IR and atherosclerosis are known to share similar genetic and environmental roots. Endothelial dysfunction (ED) detected at the earliest stages of IR might be the origin of atherosclerosis progression. ED influences the secretion of pro-inflammatory cytokines and their encoding genes. The genes and their single nucleotide polymorphisms (SNPs) act as potential genetic markers of IR and atherosclerosis. This review focuses on the link between IR, T2DM, atherosclerosis, CAD, and the potential genetic markers CHI3L1, CD36, LEPR, RETN, IL-18, RBP-4, and RARRES2 genes.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Insulin resistance implications for type II diabetes mellitus and coronary heart disease
    Haffner, SM
    Miettinen, H
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (02): : 152 - 162
  • [42] Insulin resistance and atherosclerosis in diabetes mellitus
    Wollesen, F
    Berglund, L
    Berne, C
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08): : 941 - 948
  • [43] Glycemic Management in Patients With Coronary Artery Disease and Prediabetes or Type 2 Diabetes Mellitus
    Goldfine, Allison B.
    Phua, Eng-Joo
    Abrahamson, Martin J.
    CIRCULATION, 2014, 129 (24) : 2567 - 2573
  • [44] Pulse wave velocity in patients with coronary artery disease or type 2 diabetes mellitus
    Cwynar, Marcin
    Gasowski, Jerzy
    Gryglewska, Barbara
    Dubiel, Marzena
    Grodzicki, Tomasz
    ACTA CARDIOLOGICA, 2006, 61 (04) : 421 - 426
  • [45] Relationship between Coronary Artery Disease and Retinopathy in Patients with Type 2 Diabetes Mellitus
    Kawasaki, Satsuki
    Misawa, Haruo
    Tamura, Yasushi
    Kondo, Yoshinobu
    Satoh, Shinobu
    Hasegawa, Osamu
    Kato, Satoshi
    Terauchi, Yasuo
    INTERNAL MEDICINE, 2013, 52 (22) : 2483 - 2487
  • [46] Adiponectin Gene Polymorphism in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease
    El-Menyar, Ayman
    Rizk, Nasser
    Al Suwaidi, Jassim
    CIRCULATION, 2010, 122 (02) : E320 - E321
  • [47] Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease
    Raza, Muhammad T.
    Sharif, Sabira
    Khan, Zohaib Ahmad
    Naz, Sadaf
    Mushtaq, Samsam
    Umer, Amina
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [48] High Risk for the Development of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease
    Saely, Christoph H.
    Vonbank, Alexander
    Rein, Philipp
    Drexel, Heinz
    CIRCULATION, 2013, 127 (12)
  • [49] Apob48 as a Marker of Atherosclerosis in Patients with Familial Lipid Disorders, Type 2 Diabetes Mellitus and Coronary Artery Disease
    Alipour, A.
    Valdivielso, P.
    Elte, J. W. F.
    Janssen, J. W.
    Rioja, J.
    Njo, T. L.
    Gonzaalez-Santos, P.
    Rietveld, A. P.
    Castro Cabezas, M.
    CIRCULATION, 2010, 122 (21)
  • [50] ApoB48 as a Marker of Atherosclerosis in Patients with Familial Lipid Disorders, Type 2 Diabetes Mellitus and Coronary Artery Disease
    Alipour, A.
    Valdivielso, P.
    Elte, J. W. F.
    Janssen, J. W.
    Rioja, Jose
    Njo, T. L.
    Gonzalez-Santos, P.
    Rietveld, A. P.
    Cabezas, M. Castro
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (01) : 68 - 69